Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 10850444
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin.

  1999cited by this paper
• Multidrug Resistance (MDR1) P-glycoprotein Enhances Esterification of Plasma Membrane Cholesterol*

  1999cited by this paper
• Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives.

  1999influential reference
• Drug resistance: still on the learning curve.

  1999cited by this paper
• Multidrug resistance in human tumors--molecular diagnosis and clinical significance.

  1999cited by this paper
• In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance

  1999influential reference
• Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.

  1998influential reference
• The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite.

  1998cited by this paper
• P-glycoprotein expression and prognostic value in acute myeloid leukemia.

  1998cited by this paper
• Pharmacological insights from P-glycoprotein knockout mice.

  1998cited by this paper
• Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP.

  1998cited by this paper
• Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins.

  1998cited by this paper
• Human liver microsomal metabolism of paclitaxel and drug interactions

  1998cited by this paper
• Multidrug resistance mediated by the ATP‐binding cassette transporter protein MRP

  1998cited by this paper
• Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.

  1998cited by this paper
• PSC-833, a frontier in modulation of P-glycoprotein mediated multidrug resistance

  1998cited by this paper
• Paraproteins and complement depletion: pathogenesis and clinical syndromes.

  1997cited by this paper
• Multidrug resistance: molecular mechanisms and clinical relevance

  1997cited by this paper
• Pharmacologic approaches to reversing multidrug resistance.

  1997cited by this paper
• P-glycoprotein expression in de novo acute myeloid leukemia.

  1997cited by this paper
• Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

  1997cited by this paper
• Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

  1997cited by this paper
• Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.

  1997cited by this paper
• Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein.

  1997influential reference
• Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.

  1996influential reference
• P-glycoprotein expression in patients with acute leukemia-clinical relevance.

  1996cited by this paper
• MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer.

  1996cited by this paper
• MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors.

  1996cited by this paper
• Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia.

  1996cited by this paper
• Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.

  1995cited by this paper
• Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.

  1995cited by this paper
• Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein.

  1995cited by this paper
• Extent and persistence of P-glycoprotein inhibition in multidrug-resistant P388 cells after exposure to resistance-modifying agents.

  1994cited by this paper
• Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.

  1994cited by this paper
• Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection.

  1994cited by this paper
• In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

  1993influential reference
• Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase.

  1992cited by this paper
• P‐glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines

  1991cited by this paper
• Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.

  1991cited by this paper
• A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases.

  1988influential reference
• Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts

  1988cited by this paper
• In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.

  1978cited by this paper
• In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.

  1978cited by this paper

• Research Progress on the Mechanisms of Action, Pharmacological Activities and Clinical Application of P-glycoprotein Inhibitors.

  2026cites this paper
• The Role of P-Glycoprotein (P-gp) in Cancer Multidrug Resistance (MDR): Challenges for Inhibiting P-gp in the Context of Overcoming MDR

  2023cites this paper
• Design, Synthesis, and Biological Evaluation of Marine Lissodendrins B Analogues as Modulators of ABCB1-Mediated Multidrug Resistance

  2023cites this paper
• Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state

  2022cites this paper
• Non-ionic Surfactants as a P-Glycoprotein(P-gp) Efflux Inhibitor for Optimal Drug Delivery—A Concise Outlook

  2022cites this paper
• A Strategy to Enhance Bioavailability of Drug Candidates: Natural Bioenhancers

  2021cites this paper
• Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs

  2021cites this paper
• Diterpenoids from Euphorbia glomerulans with potential reversal activities against P-glycoprotein-mediated multidrug resistance.

  2021cites this paper
• Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells

  2020cites this paper
• Overcoming efflux transporter-mediated resistance in cancer by using nanomedicines

  2020cites this paper
• Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells

  2020cites this paper
• ABC Family Transporters.

  2019cites this paper
• Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

  2019cites this paper
• Ce@STANPs/ZrO2 as Nanocatalyst for Multicomponent Synthesis of Isatin-Derived Imidazoles under Green Reaction Conditions

  2018cites this paper
• Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.

  2018cites this paper
• Multi-Component Synthesis of Novel Diazoles: their Characterization and Biological Evaluation

  2018cites this paper
• Anticancer Profiling for Coumarins and Related O-Naphthoquinones from Mansonia gagei against Solid Tumor Cells In Vitro

  2018cites this paper
• Crystal structure and molecular docking studies of 1,2,4,5-tetraaryl substituted imidazoles

  2018cites this paper
• Jatrophane diterpenoids from Euphorbia sororia as potent modulators against P-glycoprotein-based multidrug resistance.

  2018cites this paper
• Cell Migration Related to MDR—Another Impediment to Effective Chemotherapy?

  2018cites this paper
• Synthesis and XRD, FT-IR vibrational, UV–vis, and nonlinear optical exploration of novel tetra substituted imidazole derivatives: A synergistic experimental-computational analysis

  2018cites this paper
• Selective Cu(I) complex with phosphine-peptide (SarGly) conjugate contra breast cancer: Synthesis, spectroscopic characterization and insight into cytotoxic action.

  2018cites this paper
• Reaction strategies for synthesis of imidazole derivatives: a review

  2018cites this paper
• RETRACTED ARTICLE: Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer

  2018cites this paper
• Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study

  2018cites this paper
• Structure-activity relationship study of novel 2-aminobenzofuran derivatives as P-glycoprotein inhibitors.

  2017cites this paper
• Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport

  2017cites this paper
• Effect of P-glycoprotein Mediated Inhibition in Drug Bioavailability

  2017cites this paper
• Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.

  2017cites this paper
• Design, synthesis and biological evaluation of novel triazole-core reversal agents against P-glycoprotein-mediated multidrug resistance

  2016cites this paper
• One-pot Multi-component Synthesis of Some Pharmacologically Significant 2,4,5-Tri and 1,2,4,5-Tetrasubstituted Imidazoles: A Review

  2016cites this paper
• Discovery and Computer-Aided Drug Design Studies of the Anticancer Marine Triterpene Sipholanes as Novel P-gp and Brk Modulators

  2015cites this paper
• One-pot synthesis of multisubstituted imidazoles under solvent-free conditions and microwave irradiation using Fe3O4@SiO2–imid–PMAn magnetic porous nanospheres as a recyclable catalyst

  2015cites this paper
• Photoinduced Electron Transfer from Phenanthrimidazole to Magnetic Nanoparticles

  2015cites this paper
• Pharmacokinetic strategies to improve drug penetration and entrapment within solid tumors.

  2015cites this paper
• The effect of multidrug resistance modulator HZ08 on pharmacodynamics and pharmacokinetics of adriamycin in xenograft-nude mice.

  2015cites this paper
• RETRACTED ARTICLE: Site Specific Interaction Between TiO2 Nanoparticles and Phenanthrimidazole—A First Principles Quantum Mechanical Study

  2015cites this paper
• The role of ABC transporters in ovarian cancer progression and chemoresistance.

  2015cites this paper
• Synthesis and optical properties of phenanthromidazole derivatives for organic electroluminescent devices

  2015cites this paper
• PLASMA GLYCOPROTEIN INHIBITORS AS A NEW TARGET FOR OPTIMAL DRUG DELIVERY

  2015cites this paper
• The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28

  2015cites this paper
• Tributylhexadecylphosphonium bromide: an efficient reagent system for the one-pot synthesis of 2,4,5-trisubstituted imidazoles

  2015cites this paper
• Site Specific Interaction Between TiO2 Nanoparticles and Phenanthrimidazole—A First Principles Quantum Mechanical Study

  2015cites this paper
• Natural Product Modulators to Overcome Multidrug Resistance In Cancer

  2015cites this paper
• γ-Alumina Nanoparticle Catalyzed Efficient Synthesis of Highly Substituted Imidazoles

  2015cites this paper
• Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines

  2015cites this paper
• P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review

  2014cites this paper
• The role of ABC transporters in anticancer drug transport

  2014cites this paper
• Water-soluble and cleavable quercetin-amino acid conjugates as safe modulators for P-glycoprotein-based multidrug resistance.

  2014cites this paper
• Comparative Characterization of Mass Spectral Methods for the Study of IMIDAZO[1,5-a]QUINOXALIN-4-Ones

  2014cites this paper
• Discovery of Novel P‐Glycoprotein‐Mediated Multidrug Resistance Inhibitors Bearing Triazole Core via Click Chemistry

  2014cites this paper
• Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance.

  2014cites this paper
• Design, synthesis and evaluation of novel triazole core based P-glycoprotein-mediated multidrug resistance reversal agents.

  2014cites this paper
• Marine Natural Products with P-Glycoprotein Inhibitor Properties

  2014cites this paper
• UMMS-4 enhanced sensitivity of chemotherapeutic agents to ABCB1-overexpressing cells via inhibiting function of ABCB1 transporter.

  2014cites this paper
• ABC Transporters: Involvement in Multidrug Resistance and Drug Disposition

  2014cites this paper
• Systems biology of cisplatin resistance: past, present and future

  2014cites this paper
• Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine.

  2014cites this paper
• Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells.

  2014cites this paper
• Highly efficient and eco-friendly synthesis of 2-alkyl and 2-aryl-4,5-diphenyl-1H-imidazoles under mild conditions

  2013cites this paper
• P-glycoprotein Inhibition for Optimal Drug Delivery

  2013cites this paper
• Microwave assisted synthesis of 2,3-diaryl-6,7-dihydro-5H-pyrrolo[1,2-a]imidazoles through direct condensation of aryl 1,2-diketones and l-proline under solvent-free condition

  2013cites this paper
• Möglichkeiten der Überwindung von Chemoresistenz beim kindlichen Rhabdomyosarkom

  2013cites this paper
• 2-(3,4-Dimethoxyphenyl)-1-pentyl-4,5-diphenyl-1H-imidazole

  2013cites this paper
• Silicate fiber-based 3D cell culture system for anticancer drug screening.

  2013cites this paper
• Cytotoxic Effects and Multidrug Resistance Modulation by Five Benzophenones and a Xanthone Isolated from Hypericum Annulatum Moris SUBSP. Annulatum

  2013cites this paper
• central nervous system site inhibitor enhances survival of mice bearing hematologic malignancy at the Combined treatment with temozolomide and poly(ADP-ribose) polymerase

  2013cites this paper
• P-glycoprotein (P-gp/MDR1)/ABCB1

  2013cites this paper
• Different strategies to overcome multidrug resistance in cancer.

  2013cites this paper
• Impact of ABC transporters, glutathione conjugates in MDR and their modulation by flavonoids: an overview

  2013cites this paper
• One-pot Synthesis of 2,4,5-trisubstituted Imidazoles Catalyzed by Lipase

  2012cites this paper
• Catalytic procedures for multicomponent synthesis of imidazoles: selectivity control during the competitive formation of tri- and tetrasubstituted imidazoles

  2012cites this paper
• Design, synthesis, and cytotoxic activities of new 2,4,5-triarylimidazoles

  2012cites this paper
• Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin

  2012cites this paper
• Structure–Activity Relationships, Ligand Efficiency, and Lipophilic Efficiency Profiles of Benzophenone-Type Inhibitors of the Multidrug Transporter P-Glycoprotein

  2012cites this paper
• BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo.

  2012cites this paper
• ONE-POT SYNTHESIS OF 1, 2, 4, 5-TETRASUBSTITUTED IMIDAZOLES PROMOTED BY NANO-TICL4.SIO2

  2012cites this paper
• Three decades of P-gp inhibitors: skimming through several generations and scaffolds.

  2012cites this paper
• Short Time One-Spot Synthesis of 2, 4, 5-Trisubstit uted- Imidazoles Using Morpholinium Hydrogen Sulphate as Green and Reusable Catalysts

  2012cites this paper
• 2-(4-Methoxyphenyl)-1-pentyl-4,5-diphenyl-1H-imidazole

  2012cites this paper
• Synthesis of Substituted Imidazoles via a Multi-Component Condensation Catalyzed by p-toluene Sulfonic Acid, PTSA

  2012cites this paper
• Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes.

  2012cites this paper
• HG-829 is a potent noncompetitive inhibitor of the ATP-binding cassette multidrug resistance transporter ABCB1.

  2012cites this paper
• β-Lactam-synthon-interceded diastereoselective synthesis of functionally enriched thioxo-imidazolidines, imidazolidin-2-ones, piperazine-5,6-diones and 4,5-dihydroimidazoles

  2012cites this paper
• Oroxylin a reverses multi‐drug resistance of human hepatoma BEL7402/5‐FU cells via downregulation of P‐glycoprotein expression by inhibiting NF‐κB signaling pathway

  2012cites this paper
• RETRACTED ARTICLE: Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes

  2012cites this paper
• In vitro and In vivo Relevance of the P-glycoprotein Probe Substrates in Drug Discovery and Development: Focus on Rhodamine 123, Digoxin and Talinolol

  2011cites this paper
• N,N-bis(cyclohexanol)amine aryl esters inhibit P-glycoprotein as transport substrates.

  2011cites this paper
• Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia.

  2011cites this paper
• Sesquiterpenos dihidro-β-agarofuranos como revertidores naturales de la resistencia celular a múltiples fármacos causada por la Glicoproteína-P MDR1 humana

  2011cites this paper
• A simple and efficient method for the synthesis of highly substituted imidazoles using 3-aroylquinoxalin-2(1H)-ones

  2011cites this paper
• Combined ligand- and structure-based studies on inhibitors of P-glycoprotein

  2011cites this paper
• Investigation of the intrinsic mechanism of drug resistance in multiple myeloma

  2011cites this paper
• One-Pot Synthesis of 2,4,5-Trisubstituted Imidazoles Using MoO3/SiO2, an Efficient and Recyclable Catalyst

  2011cites this paper
• p-TSA catalysed efficient synthesis of 1,2,4,5-tetraaryl-imidazoles

  2011cites this paper
• Solvent-free reaction between acenaphthoquinone, various benzils and ammonium acetate: synthesis of 9,10-diaryl-7H-benzo[d,e]imidazo[2,1-a]isoquinolin-7-ones

  2011cites this paper
• N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).

  2010cites this paper
• Incorporation of multicellular spheroids into 3‐D polymeric scaffolds provides an improved tumor model for screening anticancer drugs

  2010cites this paper
• One-pot synthesis of tri- and tetra-substituted imidazoles using sodium dihydrogen phosphate under solvent-free conditions

  2010cites this paper
• Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors.

  2010cites this paper